Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Institut Bergonié
Intensity Therapeutics, Inc.
Eisai Inc.
Cellestia Biotech AG
Ludwig Institute for Cancer Research
Wake Forest University Health Sciences
Institut Bergonié
Novartis
City of Hope Medical Center
Incyte Corporation
Stanford University
Amgen
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Kentucky
Sandoz
INSYS Therapeutics Inc
Altor BioScience
Fred Hutchinson Cancer Center
Mast Therapeutics, Inc.